HYGEIA HC HLDGS DL-00001

HYGEIA HC HLDGS DL-00001

50I · F · Healthcare / Medical Care Facilities

1.23EUR+0.02 (+1.65%)

Price History

Full chart

Market Stats

Previous Close1.21
Open1.23
Day Range1.23 – 1.23
52-Week Range0.865 – 1.57
Volume10
Market Cap648.90M
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
50-Day Avg1.37
200-Day Avg1.53

About

Hygeia Healthcare Holdings Co., Limited operates as an oncology healthcare company in the People's Republic of China. The company owns and operates private for-profit hospitals, which offer a range of oncology healthcare and other healthcare services. It also provides radiotherapy center consulting services; and licenses its SRT equipment, as well as offers maintenance and technical support services for its SRT equipment. In addition, the company provides hospital management services. As of February 10, 2020, it operated or managed a network of 10 oncology-focused hospitals in 7 cities in 6 Provinces in the People's Republic of China. The company was founded in 2009 and is headquartered in Shanghai, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMs. Huanhuan Cheng
  • Employees2.78K
  • HeadquartersEnterprise Square, Shanghai, China, Germany
  • Websitehttp://www.hygeia-group.com.cn

Leadership

  • Ms. Huanhuan ChengExec. Director & Chief Exec. Officer
  • Ren AiExec. Director & Sr. VP

Financials

Income Statement

Currency: CNY2017-12-312018-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--2.32B3.20B4.08B4.45B4.01B
Growth (%)---+38.02%+27.57%+9.06%-9.84%
Cost of Revenue--1.56B2.17B2.79B3.12B2.99B
Gross Profit--757.50M1.03B1.29B1.33B1.02B
Gross Margin--32.72%32.19%31.55%29.90%25.53%
Operating Expense--233.49M301.68M412.08M441.87M399.60M
Operating Income--524.01M726.87M874.18M887.61M623.88M
Operating Margin--22.63%22.75%21.44%19.96%15.56%
EBITDA---831.37M1.11B1.12B700.57M
EBITDA Margin---26.02%27.22%25.14%17.48%
Net Income--441.46M476.78M682.93M598.26M164.53M
Net Income Margin--19.07%14.92%16.75%13.46%4.10%
Interest Expense--23.09M34.88M43.17M71.84M69.15M
Interest Expense % of Total Revenue--1.00%1.09%1.06%1.62%1.72%

Balance Sheet

Currency: CNY2017-12-312018-12-312019-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets---6.69B7.24B10.73B10.93B10.66B
Total Liabilities---2.21B2.30B4.48B4.25B3.88B
Total Equity---4.46B4.93B6.23B6.65B6.77B
Cash---707.07M853.77M549.74M369.07M429.24M
Net Debt---523.78M429.50M2.17B2.41B2.01B

Cash Flow

Currency: CNY2017-12-312018-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow66.83M159.94M426.25M685.38M782.84M707.13M949.98M
Investing Cash Flow84.20M-262.46M-----
Financing Cash Flow-47.30M12.40M-----
Capital Expenditure229.28M287.65M669.01M606.90M940.82M615.11M483.58M
Free Cash Flow---242.76M78.47M-157.98M92.02M466.39M
Dividends Paid--74.08M-94.48M--
FCF to OCF---56.95%11.45%-20.18%13.01%49.10%
Dividend Paid to FCF---30.52%--59.81%--

Key Statistics & Ratios

Market Cap648.90M
Enterprise Value866.59M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.21
Price / Book0.70
Revenue (TTM)0
Gross Profit (TTM)326.97M
Profit Margin2.44%
Operating Margin0.00%
Return on Equity0.00%
Return on Assets0.00%
Shares Outstanding0
Shares Float259.78M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.02Jun 30, 2023
20211×
0.02Jun 30, 2021